Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEO82V)

• Drug Name: ARI-3531 Drug Info
• Synonyms: compound 22 [PMID: 23594271]

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Cross-matching ID:
  PubChem CID: 91827371
  TTD Drug ID: DMEO82V

Molecule-Related Drug Atlas

Drug(s) Targeting Prolyl endopeptidase (PREP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BAICALEIN	DM4C7E6	Influenza virus infection	1E30-1E32	Phase 2	[2]
ALV-003	DMXSFA0	Coeliac disease	DA95	Phase 2	[3]
ONO-1603	DMKIZAL	Cognitive impairment	6D71	Phase 2	[4]
S-17092-1	DMYR1K8	Cognitive impairment	6D71	Phase 1	[5]
JTP-4819	DMI0UJS	Cognitive impairment	6D71	Discontinued in Phase 2	[6]
Z-321	DMLO2QY	Parkinson disease	8A00.0	Discontinued in Phase 1	[7]
BAICALIN	DMY1TLZ	Human immunodeficiency virus infection	1C62	Terminated	[8]
Y-29794	DMLAVES	N. A.	N. A.	Terminated	[8]
Double Oxidized Cysteine	DM6TU84	Discovery agent	N.A.	Investigative	[9]
Monothioglycerol	DMENSOZ	Discovery agent	N.A.	Investigative	[9]

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Prolyl endopeptidase (PREP)	TTNGKET	PPCE_HUMAN	Inhibitor	[1]

References

• [1] Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase. J Med Chem. 2013 May 9;56(9):3467-77.
• [2] Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor. Bioorg Med Chem. 2008 Aug 1;16(15):7516-24.
• [3] The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo. Clin Immunol. 2010 Mar;134(3):289-95.
• [4] ONO-1603, a potential antidementia drug, shows neuroprotective effects and increases m3-muscarinic receptor mRNA levels in differentiating rat cerebellar granule neurons. Neurosci Lett. 1996 Aug 23;214(2-3):151-4.
• [5] Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocyte-stimulating hormone breakdown in the rat brain. J Neurochem. 2003 Mar;84(5):919-29.
• [6] A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. Behav Brain Res. 1997 Feb;83(1-2):147-51.
• [7] Z-321, a prolyl endopeptidase inhibitor, augments the potentiation of synaptic transmission in rat hippocampal slices. Behav Brain Res. 1997 Feb;83(1-2):213-6.
• [8] Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J Med Chem. 2010 May 13;53(9):3423-38.
• [9] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.